X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs DR. DATSONS LABS - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD DR. DATSONS LABS BIOCON LTD/
DR. DATSONS LABS
 
P/E (TTM) x 51.4 -10.9 - View Chart
P/BV x 7.5 0.2 4,610.0% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 BIOCON LTD   DR. DATSONS LABS
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
DR. DATSONS LABS
Mar-14
BIOCON LTD/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,188126 945.9%   
Low Rs30531 987.1%   
Sales per share (Unadj.) Rs68.7133.0 51.7%  
Earnings per share (Unadj.) Rs7.60.2 4,981.0%  
Cash flow per share (Unadj.) Rs14.06.6 211.4%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.10-  
Book value per share (Unadj.) Rs86.3128.8 67.0%  
Shares outstanding (eoy) m600.0031.66 1,895.1%   
Bonus/Rights/Conversions ISFCCB-  
Price / Sales ratio x10.90.6 1,846.1%   
Avg P/E ratio x98.9516.1 19.2%  
P/CF ratio (eoy) x53.411.8 451.2%  
Price / Book Value ratio x8.60.6 1,422.9%  
Dividend payout %13.20-   
Avg Mkt Cap Rs m447,9002,477 18,079.5%   
No. of employees `0006.1NA-   
Total wages/salary Rs m9,31156 16,626.8%   
Avg. sales/employee Rs Th6,705.8NM-  
Avg. wages/employee Rs Th1,514.2NM-  
Avg. net profit/employee Rs Th736.9NM-  
INCOME DATA
Net Sales Rs m41,2344,211 979.3%  
Other income Rs m2,06279 2,620.1%   
Total revenues Rs m43,2964,289 1,009.4%   
Gross profit Rs m8,291569 1,458.1%  
Depreciation Rs m3,851204 1,884.1%   
Interest Rs m615430 143.0%   
Profit before tax Rs m5,88713 46,354.3%   
Minority Interest Rs m2130-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5696 25,721.3%   
Profit after tax Rs m4,5315 94,395.8%  
Gross profit margin %20.113.5 148.9%  
Effective tax rate %26.748.0 55.5%   
Net profit margin %11.00.1 9,639.0%  
BALANCE SHEET DATA
Current assets Rs m41,4866,852 605.5%   
Current liabilities Rs m21,4136,711 319.1%   
Net working cap to sales %48.73.3 1,453.7%  
Current ratio x1.91.0 189.8%  
Inventory Days Days64161 39.8%  
Debtors Days Days94318 29.6%  
Net fixed assets Rs m50,6613,673 1,379.3%   
Share capital Rs m3,000317 947.6%   
"Free" reserves Rs m48,8083,761 1,297.7%   
Net worth Rs m51,8084,078 1,270.6%   
Long term debt Rs m17,8981,671 1,071.2%   
Total assets Rs m99,89712,633 790.8%  
Interest coverage x10.61.0 1,026.9%   
Debt to equity ratio x0.30.4 84.3%  
Sales to assets ratio x0.40.3 123.8%   
Return on assets %5.23.4 149.6%  
Return on equity %8.70.1 7,429.3%  
Return on capital %9.67.7 125.5%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m12,058964 1,250.8%   
Fx outflow Rs m7,348607 1,210.3%   
Net fx Rs m4,710357 1,319.7%   
CASH FLOW
From Operations Rs m6,6211,345 492.3%  
From Investments Rs m-6,840-2,256 303.2%  
From Financial Activity Rs m-2,397-1,200 199.8%  
Net Cashflow Rs m-2,612-2,111 123.8%  

Share Holding

Indian Promoters % 40.4 4.5 891.8%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 1.4 792.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 94.1 21.1%  
Shareholders   109,995 20,807 528.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views on News

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Players in an Oligopoly Should Have Financials Like This(Chart Of The Day)

Dec 7, 2018

This stock has corrected 30% from peak and looks attractive at these valuations.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Dec 14, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD 8-QTR ANALYSIS

COMPARE BIOCON LTD WITH

MARKET STATS